Virbac SA
SWB:V16
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Virbac SA
SWB:V16
|
FR |
|
E
|
Edison International
SWB:EIX
|
US |
|
P
|
Pharmedic Pharmaceutical Medicinal JSC
VN:PMC
|
VN |
|
China Sunshine Paper Holdings Co Ltd
HKEX:2002
|
CN |
|
C
|
China Southern Airlines Co Ltd
HKEX:1055
|
CN |
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
SA |
|
Amalgamated Financial Corp
NASDAQ:AMAL
|
US |
|
NEXTDC Ltd
ASX:NXT
|
AU |
|
ASR Nederland NV
OTC:ASRRF
|
NL |
|
C
|
CGE Transmision SA
SGO:CGET
|
CL |
|
Adastra Holdings Ltd
OTC:XTXXF
|
CA |
|
Race Eco Chain Ltd
BSE:537785
|
IN |
|
L
|
Liaoning Port Co Ltd
HKEX:2880
|
CN |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XHAN:AUS
|
AT |
|
Asuransi Ramayana Tbk PT
IDX:ASRM
|
ID |
|
L
|
Lennox International Inc
F:LXI
|
US |
|
L
|
Lohakit Metal PCL
SET:LHK
|
TH |
|
Garnet Construction Ltd
BSE:526727
|
IN |
|
Veolia Environnement SA
PAR:VIE
|
FR |
Bankruptcy Probability
Virbac SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Virbac SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Virbac SA
PAR:VIRP
|
2.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
635.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
392.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
358.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
198.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
270.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
171.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Virbac SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Virbac SA has total debt of 253.4m EUR. This includes both short-term (13.6m EUR) and long-term (239.7m EUR) debt.
You can find a full breakdown on its Balance Sheet.